-
Description
-
Why Us?
This vaccine is not included in the Hong Kong Department of Health's "Child Immunization Programme."
Vaccine Introduction:
Meningococcal infections are infectious diseases caused by Neisseria meningitidis, transmitted through the secretions from the mouth and nose of infected individuals. Initial symptoms are often subtle, but severe conditions can arise when the bacteria invade the bloodstream (meningococcemia) or the membranes of the brain and spinal cord (epidemic meningitis), which can be severe and potentially fatal.
Meningococcal infections are not common, so this vaccine is not included in the childhood vaccination program. However, outbreaks have occurred in various regions of China, and it is recommended that young children or close contacts who frequently travel to mainland China consider getting vaccinated for protection.
- The only meningococcal vaccine approved by both the U.S. FDA and the European EMA in Hong Kong.
- Antibody levels for type C are 16.3 times higher than similar products.
Manufacturer Name: SANOFI PASTEUR
Vaccine Production Location: France
Vaccine Type:
Novel conjugate vaccine, suitable for children.
Suitable Population and Recommended Injection Times and Dosages:
- Individuals aged 1 year and above: 1 dose
This vaccine is not included in the Hong Kong Department of Health's "Child Immunization Programme."
Registration Year:
Hong Kong Registration Number: HK-67394
2022 (Hong Kong Registration)
Certification:
- FDA (2020)
- EMA (2020)
- Hong Kong Department of Health (2022)
Clearbridge Health Limited is an integrated healthcare group with a focus on the delivery of precision medicine with businesses comprising of laboratory testing services, medical centres/clinics and strategic equity participation in complementary precision medical technology companies. We are present in more than 10 countries around the world and have plans to further expand our presence in Pan Asia. Working closely with healthcare professionals and globally-accredited laboratories, Clearbridge Health offers patient care through precision diagnostics, empowers clinicians and healthcare professionals to make reliable and accurate diagnoses, providing fresh insights into disease management, customising prevention and treatment programmes that are personalised and timely. Listed on the Catalist Board of the SGX-ST, Clearbridge Health Limited Group of Companies continues to provide effective ways to detect cancer, critical illness, and other lifestyle diseases in the world today.
VISION
Redefining healthcare in Asia with precision.
Empowering patient care with clarity.
MISSION
Setting a new standard for personalized care through the integration of healthcare services, medical technology and data science.
CORE VALUES
Kindness You always come first
Confidence We believe that better outcomes start with precise insights
Dependability Our people – they are our edge
Respect Professionalism in every circumstance
Trust Delivering healthcare services with utmost integrity